[Food Navigator] CBD body announces safety study consortium as Novel Foods crunch time looms
Ahead of the UK Food Standards Agency’s 31 March 2021 deadline for CBD products to have a validated novel foods application, the Association for the Cannabinoid Industry (ACI), which works to create a safe, legal and well-regulated CBD market in the UK, says it will lead a consortium to study the safety of CBD and decide the ingredient’s recommended daily dose.
[Nutra Ingredients] FSA provides clarity to ACI members’ CBD Novel Foods Queries.
The ACI have received clarification from the Food Standards Agency regarding updated deadlines set for Cannabinoid firms to apply for Novel Foods.
[Health Europa] FSA provides clarification concerning CBD Novel Foods applications
The FSA clarified that several products may fall within the scope of a single CBD Novel Foods application, meaning that the finished product must be made with the applied for substance, for example, a CBD extract made by ‘X’ manufacturer, and that ‘the end use or presentation of the finished products is within the ‘uses’ identified by the application’, such as 5% CBD extract in oil.
[New Food Magazine] FSA clarifies CBD novel food application questions
Members from the Association for the Cannabinoid Industry (ACI) recently raised questions regarding CBD novel food dossier applications in the UK, and the FSA has now responded to their questions in a Q&A.
[New Food Magazine] Industry body in talks with LGC to standardise cannabinoid testing
The ACI has said it is an essential step towards standardisation for the industry, and the announcement comes after months of with an analytical testing laboratory, who scrutinised the produced protocols and demonstrated them to be ‘robust’.
[Times of CBD] ACI Cannabinoid Industry Authority to Develop Standardized CBD Testing in UK
A lack of harmonization in testing for cannabinoids led to important questions regarding product labeling and the analytical methodology used to declare the percentage of CBD and controlled cannabinoids on CBD products. Up to now there has been no standard analytical methodology for CBD product testing.
[Health MJ] UK Group Proposes Standardized CBD Testing System
The standardized cannabinoid testing will allow labs to detect levels to a higher degree of precision (approximately 0.0001%). Labs will identify whether samples contain more than 0.0001% of controlled cannabinoids (equivalent to 1mg/kg).
[Health Europa] ACI Lays foundation for harmonisation of cannabinoid testing
The Association for the Cannabinoid Industry (The ACI) has today announced high-level discussions with the Laboratory of Government Chemists (LGC) that will focus on the development of a cannabinoid testing methodology.
[Natural Products Global] ACI Takes ‘Essential Step’ Towards CBD test standardisation
UK trade group the Association for the Cannabinoid Industry says it has entered into discussions wit international life sciences testing company LGC in a move it says represents an ‘essential step towards standardisation for the CBD industry’.
[Analytical Cannabis] The ACI Sets its First Standards for CBD Testing in the UK
The ACI announced today that, in partnership with the lab company Eurofins and the Laboratory of Government Chemists (LGC), a testing company and UK government advisor, it has set the first lab standards for detecting cannabinoids in CBD products sold in the UK.
